Merck Zocor Administered Earlier, At Higher Dose Following sNDA Approval
Executive Summary
Merck's Zocor can be administered earlier than other statins and at a higher starting dose following FDA approval of a supplemental NDA April 16
You may also be interested in...
Bristol Pravachol Ads Broaden Indication, FDA Warning Letter Says
FDA is asking Bristol-Myers Squibb to correct Pravachol advertising claims that the agency says broadens the indication and patient populations for which the cholesterol-lowering agent is approved
Zocor Rx Growth Picks Up In June; Merck Hopes Crestor Helps Revive Market
Zocor prescriptions appear to be picking up after a difficult first half for Merck's cholesterol lowering agent
Zocor Rx Growth Picks Up In June; Merck Hopes Crestor Helps Revive Market
Zocor prescriptions appear to be picking up after a difficult first half for Merck's cholesterol lowering agent